Group 1 - The core point of the news is that Bibeite experienced a decline in stock price and trading volume on January 27, with a drop of 2.37% and a total transaction amount of 214 million yuan [1] - On January 27, Bibeite had a financing buy amount of 21.59 million yuan, with a net financing purchase of 4.36 million yuan after repaying 17.22 million yuan [1][2] - As of January 27, the total balance of margin trading for Bibeite was 155 million yuan, which represents 6.23% of its circulating market value [2] Group 2 - Bibeite, established on January 19, 2012, is located in the Guangzhou High-tech Industrial Development Zone and focuses on the independent research and development of innovative drugs [2] - As of January 20, the number of shareholders for Bibeite was 13,000, a decrease of 7.87% from the previous period, while the average circulating shares per person increased by 8.55% to 3,560 shares [2] - For the period from January to September 2025, Bibeite reported zero revenue and a net loss attributable to shareholders of 107 million yuan [2]
必贝特1月27日获融资买入2158.85万元，融资余额1.55亿元